Información del artículo
El Texto completo está disponible en PDF
References
[1.]
V. Lyssenko, P. Almgren, D. Anevski, R. Perfekt, K. Lahti, M. Nissén, et al.
Predictors and longitudinal changes in insulin sensitivity and secretion preceding onset of type 2 diabetes.
Diabetes, 54 (2005), pp. 166-174
[2.]
Y. Horikawa, N. Oda, N.J. Cox, X. Li, M. Orho-Melander, M. Hara, et al.
Genetic variation in the gene encoding calpain-10 is associated with type 2 diabetes mellitus.
Nat Genet, 26 (2000), pp. 163-175
[3.]
H. Parikh, L. Groop.
Candidate genes for type 2 diabetes.
Reviews in Endocrine and Metabolic Disorders, 5 (2004), pp. 151-176
[4.]
S.S. Deeb, L. Fajas, M. Nemoto, J. Pihlajamäki, L. Mykkänen, J. Kuusisto, et al.
A Pro12Ala substitution in PPARgamma2 associated with decreased receptor activity, lower body mass index and improved insulin sensitivity.
Nat Genet, 20 (1998), pp. 284-287
[5.]
D. Altshuler, J.N. Hirschhorn, M. Klannemark, C.M. Lindgren, M.C. Vohl, J. Nemesh, et al.
The common PPARgamma Pro12Ala polymorphism is associated with decreased risk of type 2 diabetes.
Nat Genet, 26 (2000), pp. 76-80
[6.]
J.C. Florez, N. Burtt, P.I.W. De Bakker, P. Almgren, T. Tuomi, J. Holmkvist, et al.
Haplotype structure and genotype-phenotype correlations of the sulfonyulrea receptor (SUR1) and the islet ATP- sensitive potassium channel (kir 6.2) gene region.
Diabetes, 53 (2004), pp. 1360-1368
[7.]
A.L. Gloyn, E.R. Pearson, J.F. Antcliff, P. Proks, G.J. Bruining, A.S. Slingerland, et al.
Activating mutations in the gene encoding the ATP-sensitive potassium channel subunit Kir6.2 and permanent neonatal diabetes.
N Engl J Med, 350 (2004), pp. 1838-1849
[8.]
S.F. Grant, G. Thorleifsson, I. Reynisdottir, R. Benediktsson, A. Manolescu, J. Sáinz, et al.
Variant of transcription factor 7-like 2 (TCF7L2) gene confers risk of type 2 diabetes.
Nat Genet, 38 (2006), pp. 320-323
[9.]
V. Lyssenko, R. Lupi, P. Marchetti, S. Del Guerra, M. Orho-Melander, P. Almgren, et al.
Mechanisms by which common variants in the TCF7L2 gene increase risk of type 2 diabetes.
J Clin Invest, 117 (2007), pp. 2155-2163
[10.]
R. Saxena, B. Voigt, V. Lyssenko, N.P. Burtt, P.I. de Bakker, H. Chen, et al.
Diabetes Genetics Initiative: Genome wide association analysis identifies loci for type 2 diabetes and triglyceride levels.
Science, 316 (2007), pp. 1331-1336
[11.]
E. Zeggini, L.J. Scott, R. Saxena, B.F. Voight, J.L. Marchini, T. Hu, For the Diabetes Genetics Replication and Meta-analysis (DIAGRAM) Consortium, et al.
Meta-analysis of genome-wide association data and large-scale replication identifies several additional susceptibility loci for type 2 diabetes.
Nat Genet, 40 (2008), pp. 638-645
[12.]
V. Lyssenko, A. Jonsson, N. Pulizzi, P. Almgren, B. Isomaa, T. Tuomi, et al.
Clinical risk factors, DNA variants and the development of type 2 diabetes.
New Engl J Med, 359 (2008), pp. 2220-2232
[13.]
R. McPherson, A. Pertsemilidis, N. Kavaslar, A. Stewart, R. Roberts, D.R. Cox, et al.
A common allele on chromosome 9 associated with coronary heart disease.
Science, 316 (2007), pp. 14888-14891
[14.]
T. Frayling, N.j. Timpson, M.N. Weedon, E. Zeggini, R.M. Freathy, C.M. Lindgren, et al.
A common variant in the FTO gene is associated with body mass index and predisposes to childhood and adult obesity.
Science, 316 (2007), pp. 889-894
[15.]
K. Yasuda, K. Miyake, Y. Horikawa, K. Hara, H. Osawa, H. Furuta, et al.
Multistage genome-wide SNP association study revealed KCNQ1 as a novel susceptibility gene for type 2 diabetes mellitus in multiple ethnic groups: a report of the Millennium Genome Project of Japan.
Nat Genet, 40 (2008), pp. 1092-1097
[16.]
V. Lyssenko, C.L.F. Nagorny, M.R. Erdos, N. Wierup, A. Jonsson, P. Spégel, et al.
A common variant in the melatonin receptor gene (MTNR1B) is associated with increased risk of future type 2 diabetes and impaired early insulin secretion.
Nat Genet, 41 (2008), pp. 82-88
Copyright © 2009. Sociedad Española de Endocrinología y Nutrición